The drug discovery segment is poised to further enhance market expansion, driven by increasing investments in research and development from pharmaceutical companies. Additionally, the growing prevalence of diabetes and cardiovascular diseases is creating a favorable environment for market growth. The rapid increase in the availability of drugs targeting chronic diseases worldwide is also contributing to the overall positive trajectory of the market.